Biogen (NASDAQ: BIIB) announced that the former CEO of Sanofi, Christopher Viehbacher, will take over as its President, CEO, and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE